Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126529011 | 12652901 | 1 | I | 201604 | 20160719 | 20160815 | 20160815 | EXP | CN-GILEAD-2016-0224703 | GILEAD | 70.00 | YR | E | F | Y | 0.00000 | 20160815 | MD | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126529011 | 12652901 | 1 | PS | VIREAD | TENOFOVIR DISOPROXIL FUMARATE | 1 | Oral | UNK | 21356 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126529011 | 12652901 | 1 | Hepatitis B |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126529011 | 12652901 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126529011 | 12652901 | Alanine aminotransferase increased | |
| 126529011 | 12652901 | Aspartate aminotransferase increased | |
| 126529011 | 12652901 | Drug dose omission | |
| 126529011 | 12652901 | Drug ineffective | |
| 126529011 | 12652901 | Treatment noncompliance | |
| 126529011 | 12652901 | Viral load increased | |
| 126529011 | 12652901 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126529011 | 12652901 | 1 | 2015 | 0 |